PE20030510A1 - Indoles sustituidos - Google Patents
Indoles sustituidosInfo
- Publication number
- PE20030510A1 PE20030510A1 PE2002001055A PE2002001055A PE20030510A1 PE 20030510 A1 PE20030510 A1 PE 20030510A1 PE 2002001055 A PE2002001055 A PE 2002001055A PE 2002001055 A PE2002001055 A PE 2002001055A PE 20030510 A1 PE20030510 A1 PE 20030510A1
- Authority
- PE
- Peru
- Prior art keywords
- aryl
- heteroaryl
- cycloaliphatic
- aliphatic
- radical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- AIDS & HIV (AREA)
- Anesthesiology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A INDOLES SUSTITUIDOS DE FORMULA I DONDE R1, R2, R3, R4 SON RADICAL ALIFATICO, CICLOALIFATICO, H, HALOGENO, HIDROXILO; R5 ES H, RADICAL ALIFATICO, CICLOALIFATICO, ARILO, HETEROARILO, ENTRE OTROS; R6 ES COR7, TIOL, HIDROXILO, HALOGENO, CIANO, R7 ES OR8, SR8, NR8R9; R8 Y R9 SON RADICAL ALIFATICO, CICLOALIFATICO, ARILO, HETEROARILO; A ES (CH2)(1-2), HC=CH, (CH2)nCOO, (CH2)nO(CH2)pCO, ENTRE OTROS; n ES 0-3; p ES 0-1; X ES X1, X3, ENTRE OTROS; R1' ES H, RADICAL ALIFATICO, CILOALIFATICO, ARILO, HETEROARILO; R2' ES RADICAL ALIFATICO, CICLOALIFATICO, ARILO, HETEROARILO, R3' ES RADICAL ALIFATICO, CICLOALIFATICO, ARILO, HETEROARILO; R4' ES H, ARILO, HETEROARILO, R5' ES NR6'; R6' ES RADICAL ALIFATICO, CICLOALIFATICO, ARILO, HETEROARILO. SON COMPUESTOS PREFERIDOS 4,6-DIMETIL-3-{[3'-(N,N-DIMETILAMINOMETIL)-4'-HIDROXI-4'-(3"-METOXIFENIL)-CICLOHEXILAMINO]-METIL}-1H-INDOL-2-CARBOXILATO DE ETILO; 5-METIL-3-{[3'-(N,N-DIMETILAMINOMETIL)-4'-HIDROXI-4'-(3"-METOXIFENIL)-CICLOHEXILAMINO]-METIL}-1H-INDOL-2-CARBOXILATO DE METILO; ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. LOS COMPUESTOS PUEDEN SER UTILES PARA EL TRATAMIENTO DEL DOLOR CRONICO, NEUROPATICOS, ENFERMEDADES NEURODEGENERATIVAS COMO ALZHEIMER, PARKINSON, HUNTINGTON, APOPLEJIA, ISQUEMIA CEREBRAL, INFARTO CEREBRAL, EDEMA CEREBRAL, EPILEPSIA, ESQUIZOFRENIA
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10153346A DE10153346A1 (de) | 2001-10-29 | 2001-10-29 | Substituierte Indole |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20030510A1 true PE20030510A1 (es) | 2003-07-26 |
Family
ID=7704096
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2002001055A PE20030510A1 (es) | 2001-10-29 | 2002-10-28 | Indoles sustituidos |
Country Status (14)
Country | Link |
---|---|
US (1) | US7217729B2 (es) |
EP (1) | EP1472221B1 (es) |
JP (1) | JP2005511566A (es) |
AR (1) | AR037125A1 (es) |
AT (1) | ATE321026T1 (es) |
CA (1) | CA2465236A1 (es) |
DE (2) | DE10153346A1 (es) |
DK (1) | DK1472221T3 (es) |
ES (1) | ES2261748T3 (es) |
HU (1) | HUP0402076A2 (es) |
PE (1) | PE20030510A1 (es) |
PL (1) | PL369850A1 (es) |
PT (1) | PT1472221E (es) |
WO (1) | WO2003037863A2 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005005411A1 (en) * | 2003-07-04 | 2005-01-20 | Glaxosmithkline S.P.A. | Substituted indole ligands for the orl-1 receptor |
DE102004036349A1 (de) * | 2004-07-27 | 2006-03-23 | Grünenthal GmbH | Substituierte 3-Phenylpiperidin-Derivate |
EP1676843A1 (en) * | 2004-12-31 | 2006-07-05 | Nikem Research S.R.L. | Substituted indole ligands for the ORL-1 receptor |
EP1873150A1 (en) * | 2006-06-30 | 2008-01-02 | Nikem Research S.R.L. | Fluorinated indoleamides useful as ligands of the ORL-1 receptor |
EP2134685B1 (en) | 2007-04-16 | 2015-09-02 | AbbVie Inc. | 7-nonsubstituted indole derivatives as mcl-1 inhibitors |
US20100204247A1 (en) * | 2007-10-04 | 2010-08-12 | Duffy Joseph L | N-substituted oxindoline derivatives as calcium channel blockers |
AR070398A1 (es) | 2008-02-22 | 2010-03-31 | Gruenenthal Chemie | Derivados sustituidos de indol |
US20170174825A1 (en) * | 2014-03-18 | 2017-06-22 | The Board Of Regents For Oklahoma State University | Systems and methods for production of artificial eumelanin |
DE102014221848A1 (de) * | 2014-10-27 | 2016-04-28 | Volkswagen Ag | Wasserabscheider mit Steigrohr und Dichteinrichtung, sowie Brennstoffzelle mit Wasserabscheider, und Kraftfahrzeug mit Brennstoffzelle |
EP3350166A4 (en) * | 2015-09-16 | 2019-05-01 | Metacrine, Inc. | FARNESOID-X RECEPTOR AGONISTS AND USES THEREOF |
US20230027752A1 (en) * | 2019-11-06 | 2023-01-26 | Fudan University | Opioid receptor agonist, preparation method therefor and pharmaceutical use thereof |
CN112759545B (zh) * | 2019-11-06 | 2022-12-13 | 复旦大学 | 3-(二甲氨基甲基)哌啶-4-醇类衍生物及其制备方法和药物用途 |
CN112759587B (zh) * | 2019-11-06 | 2022-12-30 | 复旦大学 | 3-(二甲氨基甲基)哌啶-4-醇类衍生物及其制备方法和药物用途 |
CN112759544B (zh) * | 2019-11-06 | 2022-08-26 | 复旦大学 | 3-(二甲氨基甲基)哌啶-4-醇衍生物制备方法和药物用途 |
CN112759546B (zh) * | 2019-11-06 | 2022-08-26 | 复旦大学 | 3-(二甲氨基甲基)哌啶-4-醇衍生物及其制备方法和药物用途 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB925429A (en) * | 1960-04-01 | 1963-05-08 | Irwin Neisler & Co | Indole derivatives |
BE610830A (es) * | 1960-12-01 | |||
JPS5116677A (ja) * | 1974-07-29 | 1976-02-10 | Sumitomo Chemical Co | Shinkinabuchirofuenonjudotai oyobi sonosanfukaennoseiho |
CH635584A5 (en) * | 1977-03-11 | 1983-04-15 | Hoechst Ag | Process for preparing novel benzoylpiperidylalkyl indoles and related compounds |
US4113866A (en) * | 1977-04-01 | 1978-09-12 | The Upjohn Company | Analgetic compounds, compositions and process of treatment |
US5145845A (en) * | 1991-05-14 | 1992-09-08 | Warner-Lambert Co. | Substituted 2-carboxylindoles having pharmaceutical activity |
NZ243065A (en) * | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
GB9321221D0 (en) | 1993-10-14 | 1993-12-01 | Glaxo Spa | Heterocyclic compounds |
DE19525137C2 (de) | 1995-07-11 | 2003-02-27 | Gruenenthal Gmbh | 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe |
ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
US5922752A (en) * | 1997-06-11 | 1999-07-13 | Hoechst Marion Roussell, Inc. | NMDA (n-methyl-d-aspartate) antagonists |
US6632836B1 (en) * | 1998-10-30 | 2003-10-14 | Merck & Co., Inc. | Carbocyclic potassium channel inhibitors |
DE19963177A1 (de) * | 1999-12-27 | 2001-07-12 | Gruenenthal Gmbh | Substanzbibliothek |
DE19963178A1 (de) * | 1999-12-27 | 2001-07-05 | Gruenenthal Gmbh | Substituierte Indol-Mannichbasen |
DE10049481A1 (de) | 2000-09-29 | 2002-05-02 | Gruenenthal Gmbh | Substituierte C-Cyclohexylmethylamin-Derivate |
DE10135636A1 (de) | 2001-07-17 | 2003-02-06 | Gruenenthal Gmbh | Substituierte 4-Aminocyclohexanole |
DE10135637A1 (de) | 2001-07-17 | 2003-02-06 | Gruenenthal Gmbh | Substituierte 4-Aminocyclohexanolderivate |
-
2001
- 2001-10-29 DE DE10153346A patent/DE10153346A1/de not_active Withdrawn
-
2002
- 2002-10-23 PL PL02369850A patent/PL369850A1/xx not_active Application Discontinuation
- 2002-10-23 ES ES02781281T patent/ES2261748T3/es not_active Expired - Lifetime
- 2002-10-23 AT AT02781281T patent/ATE321026T1/de active
- 2002-10-23 JP JP2003540145A patent/JP2005511566A/ja active Pending
- 2002-10-23 DK DK02781281T patent/DK1472221T3/da active
- 2002-10-23 WO PCT/EP2002/011831 patent/WO2003037863A2/de active IP Right Grant
- 2002-10-23 HU HU0402076A patent/HUP0402076A2/hu unknown
- 2002-10-23 DE DE50206164T patent/DE50206164D1/de not_active Expired - Lifetime
- 2002-10-23 EP EP02781281A patent/EP1472221B1/de not_active Expired - Lifetime
- 2002-10-23 PT PT02781281T patent/PT1472221E/pt unknown
- 2002-10-23 CA CA002465236A patent/CA2465236A1/en not_active Abandoned
- 2002-10-28 PE PE2002001055A patent/PE20030510A1/es not_active Application Discontinuation
- 2002-10-29 AR ARP020104100A patent/AR037125A1/es unknown
-
2004
- 2004-04-26 US US10/831,937 patent/US7217729B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2261748T3 (es) | 2006-11-16 |
DK1472221T3 (da) | 2006-07-31 |
WO2003037863A3 (de) | 2004-08-12 |
AR037125A1 (es) | 2004-10-20 |
WO2003037863A2 (de) | 2003-05-08 |
PL369850A1 (en) | 2005-05-02 |
JP2005511566A (ja) | 2005-04-28 |
PT1472221E (pt) | 2006-08-31 |
US7217729B2 (en) | 2007-05-15 |
CA2465236A1 (en) | 2003-05-08 |
US20040225003A1 (en) | 2004-11-11 |
EP1472221B1 (de) | 2006-03-22 |
HUP0402076A2 (hu) | 2005-02-28 |
DE50206164D1 (de) | 2006-05-11 |
DE10153346A1 (de) | 2004-04-22 |
ATE321026T1 (de) | 2006-04-15 |
EP1472221A2 (de) | 2004-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20030510A1 (es) | Indoles sustituidos | |
PE20011047A1 (es) | Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas | |
HN2001000099A (es) | Nuevos derivados del fenil-propargiileter | |
PE20010211A1 (es) | Compuestos de tiazol y composiciones farmaceuticas para inhibir las quinasas de proteina | |
PE20010645A1 (es) | Compuestos espiro como antagonistas de los receptores del neuropeptido y | |
PE20030039A1 (es) | Derivados de indol con afinidad por el receptor 5-ht6 | |
PE20020593A1 (es) | Activadores de glucocinasa del tipo isoindolin-2-ona | |
PE20011066A1 (es) | PIRIDO [2,3-d] PIRIMIDIN-2,7-DIAMINAS INHIBIDORES DE CINASAS | |
AR039673A1 (es) | Derivados de heteroarilamida benzocondensada de tienopiridinas utiles como agentes terapeuticos, composiciones farmaceuticas que incluyen a los mismos y metodos para su aplicacion | |
PE20060555A1 (es) | Derivados de pirrol-oxindol como moduladores del receptor de progesterona | |
PE20060689A1 (es) | Derivados de sulfonamidas como antagonistas de receptores orexina 2 | |
PE20040165A1 (es) | Uso de analogos del benzimidazol en el tratamiento de la proliferacion celular | |
PE20070115A1 (es) | Derivados de [1,3,5]-triazina como inhibidores de aspartil proteasas | |
ES2133416T3 (es) | Ligandos de subtipos de receptores de dopamina. | |
CO5560573A2 (es) | Derivados activos de amino-ftalazinona como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que los contienen | |
AR037907A1 (es) | Derivados de azaindolilalquilamina como ligandos de 5-hidroxitriptamina-6 | |
ECSP024342A (es) | Nuevos derivados d e fenilpropargileter | |
ES2154262T3 (es) | Uso de compuestos macrolidos para enfermedades oculares. | |
AR050274A1 (es) | Derivados triciclicos del indeno-pirrol como moduladores de la serotonina | |
PE20030718A1 (es) | Lactamas como antagonistas de taquiquininas | |
PE34297A1 (es) | Ligandos especificos del neuropeptido y1 | |
RU2006114045A (ru) | Фенил-пиперазиновые производные в качестве модуляторов мускариновых рецепторов | |
SE9702564D0 (sv) | New compounds | |
CL2020002157A1 (es) | Derivados de triazina para el tratamiento de enfermedades relacionadas con neurotrofinas. | |
PE20040267A1 (es) | Tiopirimidinas e isotiazolpirimidinas inhibidoras de quinasas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |